A comparison of DNA and RNA sequencing of total nucleic acids for metagenomics

Although metagenomics and metatranscriptomics are commonly used to identify bacteria and viruses in human samples, few studies directly compare these strategies. Researchers at the Karolinska Institutet compared DNA and RNA sequencing of bacterial and viral metagenomes and metatranscriptomes in the human cervix. Total nucleic acids from six human cervical samples were subjected to DNA and RNA sequencing. The effect of DNase-treatment before reverse transcription to cDNA were also analyzed. Similarities and differences in the metagenomic findings with the three different sequencing approaches were evaluated. A higher proportion of human sequences were detected by DNA sequencing (93%) compared to RNA sequencing without (76%) and with prior DNase-treatment (11%). On the contrary, bacterial sequences increased 17 and 91 times. However, the number of detected bacterial genera were less by RNA sequencing, suggesting that only a few contribute to most of the bacterial transcripts. The viral sequences were less by RNA sequencing, still twice as many virus genera were detected, including some RNA viruses that were missed by DNA sequencing. Metatranscriptomics of total cDNA provided improved detection of mainly transcribed bacteria and viruses in cervical swabs as well as detection of RNA viruses, compared to metagenomics.

Percentage of reads for viral genera for the 6 cervical swab samples by each of the 3 sequencing approaches (DNA sequencing, RNA sequencing and RNA sequencing with prior DNase-treatment)

Figure 4

DNA = DNA sequencing, RNA = RNA sequencing, RNA + DNase = RNA sequencing with prior DNase-treatment. CIN3 = cervical intraepithelial neoplasia stage 3, Normal = healthy without neoplasia. Other genera comprise viral genera that presented < 1% of the total viral reads. 

Arroyo Mühr LS, Dillner J, Ure AE et al. (2021) Comparison of DNA and RNA sequencing of total nucleic acids from human cervix for metagenomics. Sci Rep 11, 18852. [article]

Leave a Reply

Your email address will not be published. Required fields are marked *

*

Time limit is exhausted. Please reload CAPTCHA.